Speed, Quality & Cost - Why You Should Be Conducting Your Clinical Trials in Australia, New Webinar Hosted by Xtalks
TORONTO, October 25, 2018 (Newswire.com) - Over the last 20 years, Australia has grown to become a destination of choice for the conduct of early phase clinical trials. Rapid ethics approval and a simple notification to the Therapeutic Goods Administrations (TGA) means that from submission to FPFD it will only take on average six weeks. Coupled with the attractive R&D tax incentive program offered by the Australian Government, this swift pathway to study data can then be used to support an IND or IMPD application, allowing companies to speed up their drug development process.
Join Craig Rogers, SVP of Asia Pacific at PCI Clinical Services, Cameron Johnson, Chief Executive Officer and Managing Director of Nucleus Network Ltd, and Simone Quin, Partner at Prime Accounting and Business Advisory Services, for this live webinar to learn more and understand:
- The specific considerations required for Phase I trial design in Australia
- Australia’s R&D tax incentive program and eligibility when conducting trials in Australia
- The specific requirements for importing, manufacturing, compounding and labelling products for Australian clinical studies
The webinar including a Q&A with the audience, takes place on Tuesday, Nov. 13, 2018, at 4 p.m. EST (9 p.m. GMT).
For more information about this complimentary webinar, visit Speed, Quality & Cost – Why You Should be Conducting Your Clinical Trials in Australia.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.
Contact:
Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Email: [email protected]
Source: Xtalks
Share:
Tags: Clinical Trials, Clinical Trials Australia, Early Phase Clinical Trials, Emerging Market, Life Sciences, PCI Clinical Services, Pharma Manufacturing and Supply Chain, Pharmaceutical, Pharmaceutical Regulation, Xtalks